Bexorg
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $45M
Investors
- 5
About Bexorg
Bexorg, Inc. is a US-based company specializing in advanced technologies for drug discovery and development, particularly focused on addressing central nervous system disorders through innovative modeling solutions. Founded in 2021 by Zvonimir Vrselja (CEO) and Nenad Sestan and and headquartered in Connecticut, US, Bexorg, Inc. focuses on drug discovery solutions. In January 2026, Bexorg, Inc. Fox Foundation.Bexorg, Inc. specializes in innovative solutions for drug discovery and development, specifically targeting central nervous system (CNS) disorders. At the core of their offerings is the BrainEx platform, which utilizes donated human brains to restore molecular activity, creating a translational model that provides clinically predictive data. This platform aims to address the high failure rates of CNS clinical trials by offering a sophisticated alternative to traditional model systems, thereby accelerating the development of therapies for patients in urgent need. The company serves a diverse range of clients, including pharmaceutical firms and biotechnology companies, primarily in North America and Europe.Bexorg, Inc. generates revenue through strategic partnerships and direct collaborations with pharmaceutical and biotechnology companies seeking to advance their drug development initiatives. The company’s transactions are predominantly structured as B2B agreements, where clients access the BrainEx platform for a fee, enabling them to leverage its capabilities for drug testing and validation. These agreements may involve both upfront payments and milestone-based fees contingent upon the successful advancement of drug programs. By providing access to their proprietary technology, Bexorg not only facilitates accelerated research and development but also enhances the likelihood of successful clinical outcomes for their partners.
Who invested in Bexorg
5 investors across 1 round
See all investors in Bexorg
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 15, 2025
Amount
$45M
Investors
Questions about Bexorg
Who invested in Bexorg?
Bexorg has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bexorg raised?
Bexorg has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bexorg last raise money?
Bexorg's most recent round on record is a Series A, in Oct 2025.
What does Bexorg do?
Bexorg is a biotechnology company.
Where is Bexorg headquartered?
Bexorg is headquartered in San Francisco, US.
Which VCs invest in companies like Bexorg?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bexorg's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bexorg? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.